You have 9 free searches left this month | for more free features.

ABBV-621

Showing 1 - 25 of 118

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Eftozanermin alfa
  • +2 more
  • Atlanta, Georgia
  • +18 more
Oct 12, 2022

Psoriasis Trial in Canada, Japan, United States (Cedirogant, Placebo)

Recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Aug 4, 2022

Senile Cataract Trial in Qionghai (Cataract surgery)

Recruiting
  • Senile Cataract
  • Cataract surgery
  • Qionghai, Hainan, China
    Hainan Boao Lecheng Aier Eye Hospital
Jan 9, 2023

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-927, ABBV-181)

Active, not recruiting
  • Advanced Solid Tumors Cancer
  • Los Angeles, California
  • +21 more
Jan 20, 2023

Healthy Volunteers Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Oct 5, 2023

ABBV-951 Subcutaneous Infusion to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Oct 25, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

    Not yet recruiting
    • Recurrent ALK Positive Large B-Cell Lymphoma
    • +28 more
    • Biospecimen Collection
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 17, 2022

    Subcutaneous Infusion of ABBV-951 to Assess Change in Disease

    Not yet recruiting
    • Parkinson's Disease (PD)
      • (no location specified)
      Jun 15, 2023

      Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)

      Recruiting
      • Advanced Solid Tumors Cancer
      • New Haven, Connecticut
      • +29 more
      Dec 5, 2022

      Healthy Volunteers Trial in Anaheim, Las Vegas (ABBV-552)

      Recruiting
      • Healthy Volunteers
      • Anaheim, California
      • +1 more
      Jan 13, 2023

      B-cell Lymphoma Trial in Israel, Puerto Rico, Turkey (ABBV-623, ABBV-992)

      Terminated
      • B-cell Lymphoma
      • Ramat Gan, Tel-Aviv, Israel
      • +4 more
      Feb 2, 2023

      ABBV-154 Trial in Grayslake, Las Vegas (ABBV-154 Dose Formulation A, ABBV-154 Dose Formulation B)

      Active, not recruiting
      • ABBV-154
      • ABBV-154 Dose Formulation A
      • ABBV-154 Dose Formulation B
      • Grayslake, Illinois
      • +1 more
      Dec 19, 2022

      After Implantation of an IOL After Cataract Surgery

      Active, not recruiting
      • Ophthalmological Disorder
        • Linz, Upper Austria, Austria
          Kepler University Hospital
        Oct 3, 2023

        Upper Limb Spasticity Trial (ABBV-950, BOTOX, Placebo for ABBV-950)

        Not yet recruiting
        • Upper Limb Spasticity
        • ABBV-950
        • +2 more
        • (no location specified)
        Jul 14, 2023

        Dry Eye Syndrome Trial in Azusa (ABBV-444)

        Recruiting
        • Dry Eye Syndrome
        • Azusa, California
          Canyon City Eyecare /ID# 253652
        May 24, 2023

        Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

        Active, not recruiting
        • Cystic Fibrosis (CF)
        • Mobile, Alabama
        • +46 more
        Oct 20, 2022

        Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

        Not yet recruiting
        • Unresectable Metastatic Colorectal Cancer
        • (no location specified)
        Oct 25, 2023

        DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • +3 more
        • Louisville, Kentucky
        • +6 more
        Nov 14, 2022

        Healthy Trial (ABBV-CLS-7262)

        Not yet recruiting
        • Healthy
        • (no location specified)
        Nov 17, 2023

        Leiomyosarcoma Trial in United States (TTI-621, Doxorubicin)

        Recruiting
        • Leiomyosarcoma
        • Santa Monica, California
        • +26 more
        Jul 26, 2022

        Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

        Recruiting
        • Relapsed/Refractory Multiple Myeloma
        • Kashiwa-shi, Chiba, Japan
        • +5 more
        Jan 25, 2023

        Advanced Solid Tumors Trial in United States (ABBV-706, Cisplatin, Budigalimab)

        Recruiting
        • Advanced Solid Tumors
        • Grand Rapids, Michigan
        • +3 more
        Dec 13, 2022

        ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)

        Active, not recruiting
        • ALS
        • Amyotrophic Lateral Sclerosis
        • Irvine, California
        • +13 more
        Jan 20, 2023